Rationale for and Design of the TRUE-AHF Trial: The Effects of Ularitide on the Short-Term Clinical Course and Long-Term Mortality of Patients with Acute Heart Failure — Milton Packer (2016) | RDL Network
Rationale for and Design of the TRUE-AHF Trial: The Effects of Ularitide on the Short-Term Clinical Course and Long-Term Mortality of Patients with Acute Heart Failure
Milton Packer, Christopher M. O’Connor, John J.V. McMurray, Janet Wittes, William T. Abraham, Stefan D. Anker, Kenneth Dickstein, Gerasimos Filippatos, Richard Holcomb, Henry Krum, Aldo Maggioni, Alexandre Mebazaa, W. Frank Peacock, Mark C. Petrie, Piotr Ponikowski, Frank Ruschitzka, Dirk J. van Veldhuisen, Lisa Kowarski, Mark Schactman, Johannes Holzmeister
Ovidiu Chioncel, Alexandre Mebazaa, Veli‐Pekka Harjola, Andrew J.S. Coats, Massimo Piepoli, María G. Crespo‐Leiro, Cécile Laroche, Petar Seferović, Stefan D. Anker, Roberto Ferrari, Frank Ruschitzka, Silvia López‐Fernández, Daniela Miani, Gerasimos Filippatos, Aldo Maggioni
Giovanni Targher, Marco Dauriz, Cécile Laroche, Pier Luigi Temporelli, Mahmoud Hassanein, Petar Seferović, Jarosław Dróżdż, Roberto Ferrari, S.D. Anker, Andrew J.S. Coats, Gerasimos Filippatos, María G. Crespo‐Leiro, Alexandre Mebazaa, Massimo Piepoli, Aldo Maggioni, Luigi Tavazzi
Mihai Gheorghiade, Mazen Albaghdadi, Faı̈ez Zannad, Gregg C. Fonarow, Michael Böhm, Claudio Gimpelewicz, Jaco Botha, Shelley L. Moores, Eldrin F. Lewis, Henning Rattunde, Aldo Maggioni
Discussion(0)
No comments yet. Be the first to comment.